This article is 4 years old
Sinovac vaccine 78pct effective in Brazil trial, experts call for more details
A coronavirus vaccine developed by China's Sinovac Biotech was 78 percent effective in a late-stage Brazilian trial with no severe Covid-19 cases, researchers said on Thursday, although a lack of data details stirred calls for more transparency.
The trial results, closely watched by developing countries counting on the vaccine to begin mass inoculations to help end a raging pandemic, was below preliminary findings from Turkish researchers and lacked detailed data provided on US and European vaccines...
Verifying user
RM12.50 / month
- Unlimited access to award-winning journalism
- Comment and share your opinions on all our articles
- Gift interesting stories to your friends
- Tax deductable